Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes

Jesús Madero-Pérez1, Elena Fdez1, Belén Fernández1

  • 1Institute of Parasitology and Biomedicine 'López-Neyra', Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, Granada 18016, Spain.

Insights

Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease pathogenesis. This review links LRRK2's role in cellular trafficking deficits to its newly identified kinase substrates.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is a key factor in Parkinson's disease (PD) development.
  • LRRK2 mutations increase its kinase activity, leading to cytotoxicity, suggesting kinase inhibitors as potential therapeutics.
  • Understanding cellular deficits caused by pathogenic LRRK2 and its substrates is crucial for developing effective treatments.

Purpose of the Study:

  • To review the connection between intracellular trafficking defects and LRRK2-mediated phosphorylation.
  • To highlight newly identified LRRK2 kinase substrates involved in cellular processes.

Main Methods:

  • Literature review of studies on LRRK2, Parkinson's disease, and intracellular trafficking.
  • Analysis of recent findings on LRRK2 phosphorylation targets.
  • Synthesis of information linking LRRK2 activity to cellular dysfunction.

Main Results:

  • LRRK2 is consistently shown to impair intracellular vesicular trafficking.
  • A subset of proteins critical for trafficking are phosphorylated by LRRK2.
  • These substrates are intricately involved in the cellular deficits observed in PD.

Conclusions:

  • Pathogenic LRRK2 disrupts cellular functions through the phosphorylation of specific trafficking-related substrates.
  • Targeting LRRK2 kinase activity or its substrates may offer disease-modifying strategies for Parkinson's disease.
  • Further research into LRRK2 substrates is essential for understanding PD pathogenesis and developing novel therapies.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.3K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.7K
Recycling Endosomes and Transcytosis00:58

Recycling Endosomes and Transcytosis

The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
3.7K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
112.6K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
10.7K